Overview
Coronary artery congenital malformation (also known as congenital coronary artery anomaly or congenital coronary artery malformation) refers to a group of rare structural abnormalities of the coronary arteries that are present from birth. These anomalies involve variations in the origin, course, or structure of the coronary arteries — the blood vessels that supply oxygen-rich blood to the heart muscle. Examples include anomalous origin of a coronary artery from the pulmonary artery (ALCAPA or ARCAPA), anomalous origin of a coronary artery from the wrong aortic sinus, coronary artery fistulas, and myocardial bridging. The cardiovascular system is primarily affected, and the clinical significance varies widely depending on the specific type of malformation. Symptoms can range from completely asymptomatic presentations discovered incidentally to life-threatening conditions. In severe forms, particularly anomalous left coronary artery from the pulmonary artery (ALCAPA), infants may present with heart failure, poor feeding, irritability, and failure to thrive within the first months of life. In older children and adults, symptoms may include chest pain (angina), shortness of breath, exercise intolerance, syncope (fainting), arrhythmias, and in some cases sudden cardiac death, particularly during or after vigorous physical activity. Some anomalies, such as coronary artery fistulas, may cause a continuous heart murmur detectable on physical examination. Diagnosis is typically made through echocardiography, CT coronary angiography, MRI, or conventional coronary angiography. Treatment depends on the type and severity of the anomaly. Hemodynamically significant malformations, such as ALCAPA, generally require surgical correction, which may involve reimplantation of the anomalous coronary artery or bypass grafting. Coronary artery fistulas may be treated with surgical ligation or transcatheter embolization. Patients with certain high-risk anomalies may be advised to restrict vigorous physical activity. Prognosis is generally favorable when the condition is identified early and appropriately managed, though lifelong cardiac follow-up is often recommended.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
10 eventsOxford University Hospitals NHS Trust
The University of Hong Kong
Assiut University
Laikο General Hospital, Athens
Karolinska Institutet
Pusan National University Yangsan Hospital — NA
Oslo University Hospital
Guangdong Provincial People's Hospital
Carelon Research — NA
National Heart, Lung, and Blood Institute (NHLBI)
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Coronary artery congenital malformation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Coronary artery congenital malformation at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Coronary artery congenital malformation.
Community
No community posts yet. Be the first to share your experience with Coronary artery congenital malformation.
Start the conversation →Latest news about Coronary artery congenital malformation
Disease timeline:
New recruiting trial: Fetal Assessment of the Myocardium and Evaluation of the Neonate
A new clinical trial is recruiting patients for Coronary artery congenital malformation
New recruiting trial: Myocardial Ischemia Without Obstructive Coronary Stenoses
A new clinical trial is recruiting patients for Coronary artery congenital malformation
New recruiting trial: COMPERA / COMPERA-KIDS
A new clinical trial is recruiting patients for Coronary artery congenital malformation
New recruiting trial: Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
A new clinical trial is recruiting patients for Coronary artery congenital malformation
New recruiting trial: Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
A new clinical trial is recruiting patients for Coronary artery congenital malformation
New recruiting trial: The CACHE Study: Coronary Artery Care in HaEmophilia
A new clinical trial is recruiting patients for Coronary artery congenital malformation
New recruiting trial: Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
A new clinical trial is recruiting patients for Coronary artery congenital malformation
New recruiting trial: Effect of Local Warming for Arterial Catheterization in Pediatric Anesthesia
A new clinical trial is recruiting patients for Coronary artery congenital malformation
New recruiting trial: Wearable Assessment of Thoracic, Cardiac Health and Exercise Performance Trial
A new clinical trial is recruiting patients for Coronary artery congenital malformation
New recruiting trial: A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy
A new clinical trial is recruiting patients for Coronary artery congenital malformation
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Coronary artery congenital malformation
What is Coronary artery congenital malformation?
Coronary artery congenital malformation (also known as congenital coronary artery anomaly or congenital coronary artery malformation) refers to a group of rare structural abnormalities of the coronary arteries that are present from birth. These anomalies involve variations in the origin, course, or structure of the coronary arteries — the blood vessels that supply oxygen-rich blood to the heart muscle. Examples include anomalous origin of a coronary artery from the pulmonary artery (ALCAPA or ARCAPA), anomalous origin of a coronary artery from the wrong aortic sinus, coronary artery fistulas,
Which specialists treat Coronary artery congenital malformation?
25 specialists and care centers treating Coronary artery congenital malformation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.